Vera Therapeutics GAAP EPS of -$4.66
Source: SeekingAlpha
2026-02-26 09:46:09 ET
More on Vera Therapeutics
- Vera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade)
- Vera Therapeutics, Inc. (VERA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Vera Therapeutics, Inc. (VERA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
- Vera rises as FDA grants Priority Review to atacicept for IgA nephropathy
- Vera Therapeutics prices public offering to raise $261M at $42.50 a share
Read the full article on Seeking Alpha
For further details see:
Vera Therapeutics GAAP EPS of -$4.66
Vera Therapeutics Inc.
NASDAQ: VERA
VERA Trading
-5.93% G/L:
$40.14 Last:
572,025 Volume:
$41.04 Open:
VERA Latest News
February 26, 2026 07:30:00 am
Vera Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results
VERA Stock Data
$3,391,267,270
64,525,817
0.5%
66
N/A
Biotechnology & Life Sciences
Healthcare
US
Brisbane
